BOK Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Buy
245,008
+8,401
+4% +$490K 0.23% 90
2025
Q4
$12.8M Sell
236,607
-27,973
-11% -$1.35M 0.2% 107
2025
Q3
$11.9M Buy
264,580
+83,079
+46% +$3.88M 0.18% 114
2025
Q2
$8.4M Buy
181,501
+65,842
+57% +$3.23M 0.14% 140
2025
Q1
$7.05M Buy
115,659
+12,630
+12% +$736K 0.12% 145
2024
Q4
$5.75M Buy
103,029
+1,464
+1% +$81.8K 0.1% 177
2024
Q3
$5.5M Sell
101,565
-18,497
-15% -$868K 0.1% 179
2024
Q2
$4.99M Sell
120,062
-23,281
-16% -$1.04M 0.09% 200
2024
Q1
$7.6M Buy
143,343
+26,816
+23% +$1.37M 0.14% 155
2023
Q4
$5.98M Sell
116,527
-11,719
-9% -$615K 0.12% 175
2023
Q3
$6.61M Sell
128,246
-25,483
-17% -$1.56M 0.15% 150
2023
Q2
$9.83M Sell
153,729
-23,599
-13% -$1.58M 0.2% 112
2023
Q1
$12.3M Buy
177,328
+21,191
+14% +$1.49M 0.26% 91
2022
Q4
$11.2M Sell
156,137
-2,115
-1% -$159K 0.21% 110
2022
Q3
$11.3M Sell
158,252
-3,560
-2% -$258K 0.23% 99
2022
Q2
$12.5M Sell
161,812
-24,287
-13% -$1.85M 0.24% 97
2022
Q1
$13.6M Buy
186,099
+9,970
+6% +$669K 0.22% 98
2021
Q4
$11M Sell
176,129
-10,843
-6% -$636K 0.17% 135
2021
Q3
$11.1M Buy
+186,972
New +$12.3M 0.19% 114
2021
Q1
$12.8M Sell
203,507
-20,080
-9% -$1.25M 0.23% 100
2020
Q4
$13.9M Sell
223,587
-103,593
-32% -$6.37M 0.26% 86
2020
Q3
$19.7M Buy
327,180
+56,709
+21% +$3.41M 0.43% 56
2020
Q2
$15.9M Buy
270,471
+32,758
+14% +$1.96M 0.37% 61
2020
Q1
$13.3M Buy
237,713
+61,892
+35% +$3.78M 0.38% 61
2019
Q4
$11.3M Buy
175,821
+45,462
+35% +$2.6M 0.26% 94
2019
Q3
$6.61M Buy
130,359
+17,783
+16% +$836K 0.16% 148
2019
Q2
$5.11M Sell
112,576
-4,930
-4% -$230K 0.12% 193
2019
Q1
$5.61M Sell
117,506
-3,265
-3% -$163K 0.13% 175
2018
Q4
$6.28M Sell
120,771
-129,822
-52% -$6.98M 0.18% 136
2018
Q3
$15.6M Sell
250,593
-6,653
-3% -$395K 0.39% 58
2018
Q2
$14.2M Sell
257,246
-7,886
-3% -$426K 0.38% 60
2018
Q1
$16.8M Buy
265,132
+27,703
+12% +$1.78M 0.48% 49
2017
Q4
$14.6M Buy
237,429
+4,164
+2% +$260K 0.4% 60
2017
Q3
$14.9M Buy
233,265
+27,078
+13% +$1.58M 0.43% 57
2017
Q2
$11.5M Sell
206,187
-5,577
-3% -$303K 0.36% 68
2017
Q1
$11.5M Sell
211,764
-57,738
-21% -$3.17M 0.36% 70
2016
Q4
$15.7M Buy
269,502
+6,270
+2% +$343K 0.52% 41
2016
Q3
$14.2M Buy
263,232
+506
+0.2% +$32.5K 0.47% 46
2016
Q2
$19.3M Sell
262,726
-20,112
-7% -$1.42M 0.68% 22
2016
Q1
$18.1M Sell
282,838
-8,440
-3% -$532K 0.65% 24
2015
Q4
$20M Sell
291,278
-1,778
-0.6% -$117K 0.72% 18
2015
Q3
$17.4M Sell
293,056
-772
-0.3% -$49K 0.65% 27
2015
Q2
$19.6M Buy
293,828
+891
+0.3% +$58.7K 0.66% 26
2015
Q1
$18.9M Buy
292,937
+8,066
+3% +$505K 0.64% 29
2014
Q4
$16.8M Sell
284,871
-49,066
-15% -$2.77M 0.58% 36
2014
Q3
$17.1M Buy
333,937
+58,354
+21% +$2.91M 0.57% 32
2014
Q2
$13.4M Buy
275,583
+59,477
+28% +$2.93M 0.43% 45
2014
Q1
$11.2M Buy
216,106
+59,167
+38% +$3.15M 0.37% 54
2013
Q4
$8.34M Sell
156,939
-2,367
-1% -$121K 0.28% 79
2013
Q3
$7.37M Sell
159,306
-128,183
-45% -$5.63M 0.27% 86
2013
Q2
$12.8M Buy
+287,489
New +$12.5M 0.49% 45

Other funds holding BMY

BOK Financial's BMY Position: Q1 2026 in Review

BOK Financial increased its Bristol-Myers Squibb (BMY) stake by 3.6% in Q1 2026, buying an estimated $490K and bringing the position to 245,008 shares worth $14.9M. The position accounts for 0.23% of the portfolio, ranked #90.

BOK Financial first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $20M in Q4 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • BOK Financial held 245,008 shares of Bristol-Myers Squibb worth $14.9M as of Q1 2026.
  • BOK Financial bought 8,401 Bristol-Myers Squibb shares in Q1 2026, an estimated $490K.
  • Bristol-Myers Squibb made up 0.23% of BOK Financial's portfolio in Q1 2026, its #90 holding.
  • BOK Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • BOK Financial's Bristol-Myers Squibb position peaked at $20M in Q4 2015.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.